WAT
Waters Corporation
Price Chart
Latest Quote
$379.31
Current Price| Previous Close | $370.72 |
| Open | $368.23 |
| Day High | $379.55 |
| Day Low | $368.23 |
| Volume | 426,508 |
Stock Information
| Shares Outstanding | 59.55M |
| Total Debt | $1.54B |
| Cash Equivalents | $459.12M |
| Revenue | $3.11B |
| Net Income | $648.81M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $22.59B |
| P/E Ratio | 34.83 |
| EPS (TTM) | $10.89 |
| Exchange | NYQ |
📊 Custom Metrics & Score
Score: 16/42| Debt to Equity | 0.93 |
| Debt to Earnings | 0.97 |
| Current Ratio | 2.11 |
| Quick Ratio | 1.34 |
| Avg Revenue Growth | 1.55% |
| Profit Margin | 21.56% |
| Return on Equity | 34.88% |
| Avg FCF Growth | 1.75% |
| FCF Yield | 2.74% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $379.31 | 532,900 |
| 2026-01-30 | $370.72 | 865,200 |
| 2026-01-29 | $375.18 | 673,200 |
| 2026-01-28 | $385.03 | 382,800 |
| 2026-01-27 | $390.09 | 367,900 |
| 2026-01-26 | $390.90 | 308,500 |
| 2026-01-23 | $392.31 | 581,400 |
| 2026-01-22 | $400.42 | 521,300 |
| 2026-01-21 | $396.71 | 519,000 |
| 2026-01-20 | $383.86 | 395,100 |
| 2026-01-16 | $387.37 | 550,800 |
| 2026-01-15 | $394.59 | 393,000 |
| 2026-01-14 | $393.20 | 518,000 |
| 2026-01-13 | $394.03 | 770,300 |
| 2026-01-12 | $393.68 | 331,900 |
| 2026-01-09 | $396.75 | 493,600 |
| 2026-01-08 | $396.65 | 413,600 |
| 2026-01-07 | $399.41 | 553,800 |
| 2026-01-06 | $400.54 | 466,100 |
| 2026-01-05 | $394.97 | 433,400 |
About Waters Corporation
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
📰 Latest News
Becton, Dickinson and Company (BDX): A Bull Case Theory
Insider Monkey • 2026-02-03T01:38:48Z
Waters Corporation (WAT): A Bull Case Theory
Insider Monkey • 2026-02-03T00:49:32Z
Becton, Dickinson Shareholders Approve All Proposals at Annual Meeting, Recap Record FY2025
MarketBeat • 2026-01-31T16:37:00Z
1 Profitable Stock on Our Buy List and 2 We Avoid
StockStory • 2026-01-30T04:37:14Z
Becton Dickinson Reshapes Portfolio With Waters Deal And Recycling Progress
Simply Wall St. • 2026-01-30T04:34:45Z
Waters (WAT) Valuation Check After Recent Share Price Moves And Modest Undervaluation Estimates
Simply Wall St. • 2026-01-18T22:07:24Z
Is Waters (WAT) Still Fairly Priced After Mixed Share Returns And Rich P/E Multiple
Simply Wall St. • 2026-01-18T13:04:38Z
3 Mid-Cap Stocks We Steer Clear Of
StockStory • 2026-01-16T04:35:50Z
Waters Corporation Earnings Preview: What to Expect
Barchart • 2026-01-15T13:12:04Z
Waters Corporation expands into biosciences and diagnostics
Medical Device Network • 2026-01-13T15:18:19Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $1,055,466,000 | $1,061,876,000 | $1,124,125,000 | $1,031,996,000 |
| Cost Of Revenue | $1,200,201,000 | $1,195,223,000 | $1,248,182,000 | $1,156,533,000 |
| Total Revenue | $2,958,387,000 | $2,956,416,000 | $2,971,956,000 | $2,785,874,000 |
| Operating Revenue | $2,958,387,000 | $2,956,416,000 | $2,971,956,000 | $2,785,874,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $89,677,000 | $98,861,000 | $48,797,000 | $44,938,000 |
| Total Expenses | $2,120,466,000 | $2,138,740,000 | $2,088,764,000 | $1,959,002,000 |
| Other Income Expense | $-10,792,000 | $807,000 | $-7,569,000 | $12,038,000 |
| Other Non Operating Income Expenses | $776,000 | $807,000 | $2,228,000 | $17,203,000 |
| Net Non Operating Interest Income Expense | $-72,261,000 | $-82,240,000 | $-37,777,000 | $-32,717,000 |
| Interest Expense Non Operating | $89,677,000 | $98,861,000 | $48,797,000 | $44,938,000 |
| Operating Expense | $920,265,000 | $943,517,000 | $840,582,000 | $802,469,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Net Interest Income | $-72,261,000 | $-82,240,000 | $-37,777,000 | $-32,717,000 |
| Interest Income | $17,416,000 | $16,621,000 | $11,020,000 | $12,221,000 |
| Normalized Income | $647,608,960 | $642,234,000 | $716,033,465 | $697,279,735 |
| Net Income From Continuing And Discontinued Operation | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Total Operating Income As Reported | $826,353,000 | $817,676,000 | $873,395,000 | $821,707,000 |
| Net Income Common Stockholders | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Net Income | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Net Income Including Noncontrolling Interests | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Net Income Continuous Operations | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Pretax Income | $754,868,000 | $736,243,000 | $837,846,000 | $806,193,000 |
| Special Income Charges | $-11,568,000 | $0 | $-9,797,000 | $-5,165,000 |
| Interest Income Non Operating | $17,416,000 | $16,621,000 | $11,020,000 | $12,221,000 |
| Operating Income | $837,921,000 | $817,676,000 | $883,192,000 | $826,872,000 |
| Depreciation Amortization Depletion Income Statement | $47,090,000 | $32,558,000 | $6,366,000 | $7,143,000 |
| Depreciation And Amortization In Income Statement | $47,090,000 | $32,558,000 | $6,366,000 | $7,143,000 |
| Amortization Of Intangibles Income Statement | $47,090,000 | $32,558,000 | $6,366,000 | $7,143,000 |
| Gross Profit | $1,758,186,000 | $1,761,193,000 | $1,723,774,000 | $1,629,341,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $10.71 | $10.84 | $11.73 | $11.17 |
| Basic EPS | $10.75 | $10.87 | $11.80 | $11.25 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-1,793,040 | $0 | $-1,518,535 | $-728,265 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,047,938,000 | $1,001,009,000 | $1,026,863,000 | $987,976,000 |
| Total Unusual Items | $-11,568,000 | $0 | $-9,797,000 | $-5,165,000 |
| Total Unusual Items Excluding Goodwill | $-11,568,000 | $0 | $-9,797,000 | $-5,165,000 |
| Reconciled Depreciation | $191,825,000 | $165,905,000 | $130,423,000 | $131,680,000 |
| EBITDA (Bullshit earnings) | $1,036,370,000 | $1,001,009,000 | $1,017,066,000 | $982,811,000 |
| EBIT | $844,545,000 | $835,104,000 | $886,643,000 | $851,131,000 |
| Diluted Average Shares | $59,552,000 | $59,270,000 | $60,331,000 | $62,028,000 |
| Basic Average Shares | $59,333,000 | $59,076,000 | $59,985,000 | $61,575,000 |
| Diluted NI Availto Com Stockholders | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Tax Provision | $117,034,000 | $94,009,000 | $130,091,000 | $113,350,000 |
| Other Special Charges | $11,568,000 | - | $9,797,000 | $5,165,000 |
| Amortization | $47,090,000 | $32,558,000 | $6,366,000 | $7,143,000 |
| Research And Development | $183,027,000 | $174,945,000 | $176,190,000 | $168,358,000 |
| Selling General And Administration | $690,148,000 | $736,014,000 | $658,026,000 | $626,968,000 |
| Impairment Of Capital Assets | - | - | $0 | $0 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-35,119,000 | $-784,292,000 | $-153,239,000 | $-312,712,000 |
| Total Assets | $4,553,795,000 | $4,626,854,000 | $3,281,453,000 | $3,094,932,000 |
| Total Non Current Assets | $2,884,684,000 | $2,873,987,000 | $1,517,550,000 | $1,465,990,000 |
| Other Non Current Assets | $295,665,000 | $215,690,000 | $191,100,000 | $153,077,000 |
| Goodwill And Other Intangible Assets | $1,863,626,000 | $1,934,633,000 | $657,727,000 | $680,266,000 |
| Other Intangible Assets | $567,906,000 | $629,187,000 | $227,399,000 | $242,401,000 |
| Current Assets | $1,669,111,000 | $1,752,867,000 | $1,763,903,000 | $1,628,942,000 |
| Other Current Assets | $133,130,000 | $138,489,000 | $103,910,000 | $90,914,000 |
| Inventory | $477,261,000 | $516,236,000 | $455,710,000 | $356,095,000 |
| Receivables | $733,365,000 | $702,168,000 | $722,892,000 | $612,648,000 |
| Accounts Receivable | $733,365,000 | $702,168,000 | $722,892,000 | $612,648,000 |
| Allowance For Doubtful Accounts Receivable | $-14,269,000 | $-19,335,000 | $-14,311,000 | $-13,228,000 |
| Gross Accounts Receivable | $747,634,000 | $721,503,000 | $737,203,000 | $625,876,000 |
| Cash Cash Equivalents And Short Term Investments | $325,355,000 | $395,974,000 | $481,391,000 | $569,285,000 |
| Cash And Cash Equivalents | $324,421,000 | $395,076,000 | $480,529,000 | $501,234,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $1,302,067,000 | $1,960,437,000 | $1,094,349,000 | $1,012,636,000 |
| Total Debt | $1,702,342,000 | $2,442,264,000 | $1,663,415,000 | $1,601,399,000 |
| Long Term Debt And Capital Lease Obligation | $1,676,805,000 | $2,364,439,000 | $1,586,986,000 | $1,573,493,000 |
| Long Term Debt | $1,626,488,000 | $2,305,513,000 | $1,524,878,000 | $1,513,870,000 |
| Current Debt And Capital Lease Obligation | $25,537,000 | $77,825,000 | $76,429,000 | $27,906,000 |
| Current Debt | - | $50,000,000 | $50,000,000 | - |
| Other Current Borrowings | - | $50,000,000 | - | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $2,725,288,000 | $3,476,513,000 | $2,776,965,000 | $2,727,378,000 |
| Total Non Current Liabilities Net Minority Interest | $1,935,530,000 | $2,686,933,000 | $1,991,228,000 | $2,046,870,000 |
| Other Non Current Liabilities | $183,796,000 | $137,812,000 | $117,543,000 | $89,803,000 |
| Tradeand Other Payables Non Current | $30,318,000 | $137,123,000 | $248,496,000 | $319,547,000 |
| Current Liabilities | $789,758,000 | $789,580,000 | $785,737,000 | $680,508,000 |
| Other Current Liabilities | $149,254,000 | $168,677,000 | $140,304,000 | $155,054,000 |
| Current Deferred Liabilities | $250,807,000 | $256,675,000 | $227,908,000 | $227,561,000 |
| Payables And Accrued Expenses | $270,191,000 | $217,012,000 | $237,796,000 | $168,795,000 |
| Payables | $258,589,000 | $204,962,000 | $225,847,000 | $158,077,000 |
| Total Tax Payable | $158,658,000 | $120,257,000 | $132,545,000 | $61,278,000 |
| Income Tax Payable | $158,658,000 | $120,257,000 | $132,545,000 | $61,278,000 |
| Accounts Payable | $99,931,000 | $84,705,000 | $93,302,000 | $96,799,000 |
| Current Notes Payable | - | - | $50,000,000 | $0 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $1,828,507,000 | $1,150,341,000 | $504,488,000 | $367,554,000 |
| Total Equity Gross Minority Interest | $1,828,507,000 | $1,150,341,000 | $504,488,000 | $367,554,000 |
| Stockholders Equity | $1,828,507,000 | $1,150,341,000 | $504,488,000 | $367,554,000 |
| Gains Losses Not Affecting Retained Earnings | $-155,283,000 | $-134,120,000 | $-141,572,000 | $-111,865,000 |
| Other Equity Adjustments | $-155,283,000 | $-134,120,000 | $-141,572,000 | $-111,865,000 |
| Retained Earnings | $9,788,655,000 | $9,150,821,000 | $8,508,587,000 | $7,800,832,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $103,574,000 | $103,533,000 | $103,321,000 | $101,356,000 |
| Ordinary Shares Number | $59,388,000 | $59,176,000 | $59,104,000 | $60,728,000 |
| Share Issued | $162,962,000 | $162,709,000 | $162,425,000 | $162,084,000 |
| Tangible Book Value | $-35,119,000 | $-784,292,000 | $-153,239,000 | $-312,712,000 |
| Invested Capital | $3,454,995,000 | $3,505,854,000 | $2,079,366,000 | $1,881,424,000 |
| Working Capital | $879,353,000 | $963,287,000 | $978,166,000 | $948,434,000 |
| Capital Lease Obligations | $75,854,000 | $86,751,000 | $88,537,000 | $87,529,000 |
| Total Capitalization | $3,454,995,000 | $3,455,854,000 | $2,029,366,000 | $1,881,424,000 |
| Treasury Stock | $10,147,793,000 | $10,134,252,000 | $10,063,975,000 | $9,437,914,000 |
| Additional Paid In Capital | $2,341,298,000 | $2,266,265,000 | $2,199,824,000 | $2,114,880,000 |
| Capital Stock | $1,630,000 | $1,627,000 | $1,624,000 | $1,621,000 |
| Common Stock | $1,630,000 | $1,627,000 | $1,624,000 | $1,621,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Employee Benefits | $44,611,000 | $47,559,000 | $38,203,000 | $64,027,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $44,611,000 | $47,559,000 | $38,203,000 | $64,027,000 |
| Long Term Capital Lease Obligation | $50,317,000 | $58,926,000 | $62,108,000 | $59,623,000 |
| Current Deferred Revenue | $250,807,000 | $256,675,000 | $227,908,000 | $227,561,000 |
| Current Capital Lease Obligation | $25,537,000 | $27,825,000 | $26,429,000 | $27,906,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $93,969,000 | $69,391,000 | $103,300,000 | $101,192,000 |
| Current Accrued Expenses | $11,602,000 | $12,050,000 | $11,949,000 | $10,718,000 |
| Goodwill | $1,295,720,000 | $1,305,446,000 | $430,328,000 | $437,865,000 |
| Net PPE | $725,393,000 | $723,664,000 | $668,723,000 | $632,647,000 |
| Accumulated Depreciation | $-729,463,000 | $-752,132,000 | $-702,122,000 | $-673,516,000 |
| Gross PPE | $1,454,856,000 | $1,475,796,000 | $1,370,845,000 | $1,306,163,000 |
| Leases | $43,622,000 | $55,006,000 | $54,930,000 | $55,774,000 |
| Construction In Progress | $39,180,000 | $118,492,000 | $164,222,000 | $117,148,000 |
| Other Properties | $753,430,000 | $749,321,000 | $641,454,000 | $622,516,000 |
| Machinery Furniture Equipment | $30,013,000 | $28,675,000 | $30,582,000 | $28,236,000 |
| Buildings And Improvements | $547,666,000 | $488,667,000 | $444,994,000 | $446,061,000 |
| Land And Improvements | $40,945,000 | $35,635,000 | $34,663,000 | $36,428,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $228,428,000 | $262,086,000 | $230,051,000 | $171,129,000 |
| Work In Process | $21,801,000 | $20,198,000 | $19,899,000 | $19,726,000 |
| Raw Materials | $227,032,000 | $233,952,000 | $205,760,000 | $165,240,000 |
| Other Short Term Investments | $934,000 | $898,000 | $862,000 | $68,051,000 |
| Current Provisions | - | - | $11,949,000 | $10,718,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $619,642,000 | $442,177,000 | $428,205,000 | $579,008,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $762,123,000 | $602,809,000 | $611,661,000 | $747,274,000 |
| Cash Flow From Continuing Operating Activities | $762,123,000 | $602,809,000 | $611,661,000 | $747,274,000 |
| Operating Gains Losses | - | $-742,000 | - | - |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-142,481,000 | $-160,632,000 | $-183,456,000 | $-168,266,000 |
| Investing Cash Flow | $-144,023,000 | $-1,442,265,000 | $-107,967,000 | $-231,630,000 |
| Cash Flow From Continuing Investing Activities | $-144,023,000 | $-1,442,265,000 | $-107,967,000 | $-231,630,000 |
| Net Other Investing Changes | - | $-1,282,354,000 | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-13,541,000 | $-70,277,000 | $-626,061,000 | $-648,930,000 |
| Financing Cash Flow | $-696,675,000 | $754,951,000 | $-509,633,000 | $-438,275,000 |
| Cash Flow From Continuing Financing Activities | $-696,675,000 | $754,951,000 | $-509,633,000 | $-438,275,000 |
| Net Other Financing Charges | $16,500,000 | $15,436,000 | $13,627,000 | $-4,988,000 |
| Net Common Stock Issuance | $-13,541,000 | $-70,277,000 | $-626,061,000 | $-648,930,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-900,000,000 | $-670,040,000 | $-145,000,000 | $-350,000,000 |
| Issuance Of Debt | $170,000,000 | $1,450,040,000 | $205,000,000 | $510,000,000 |
| Interest Paid Supplemental Data | $92,096,000 | $94,099,000 | $48,083,000 | $42,408,000 |
| Income Tax Paid Supplemental Data | $183,341,000 | $243,316,000 | $160,082,000 | $153,504,000 |
| End Cash Position | $324,421,000 | $395,076,000 | $480,529,000 | $501,234,000 |
| Beginning Cash Position | $395,076,000 | $480,529,000 | $501,234,000 | $436,695,000 |
| Effect Of Exchange Rate Changes | $7,920,000 | $-948,000 | $-14,766,000 | $-12,830,000 |
| Changes In Cash | $-78,575,000 | $-84,505,000 | $-5,939,000 | $77,369,000 |
| Proceeds From Stock Option Exercised | $30,366,000 | $29,792,000 | $42,801,000 | $55,643,000 |
| Common Stock Payments | $-13,541,000 | $-70,277,000 | $-626,061,000 | $-648,930,000 |
| Net Issuance Payments Of Debt | $-730,000,000 | $780,000,000 | $60,000,000 | $160,000,000 |
| Net Long Term Debt Issuance | $-730,000,000 | $780,000,000 | $60,000,000 | $160,000,000 |
| Long Term Debt Payments | $-900,000,000 | $-670,040,000 | $-145,000,000 | $-350,000,000 |
| Long Term Debt Issuance | $170,000,000 | $1,450,040,000 | $205,000,000 | $510,000,000 |
| Net Investment Purchase And Sale | $-53,000 | $-21,000 | $66,586,000 | $-61,576,000 |
| Sale Of Investment | $3,676,000 | $1,770,000 | $77,993,000 | $218,084,000 |
| Purchase Of Investment | $-3,729,000 | $-1,791,000 | $-11,407,000 | $-279,660,000 |
| Net Business Purchase And Sale | $-1,489,000 | $-1,281,612,000 | $8,903,000 | $-1,788,000 |
| Purchase Of Business | $0 | $-1,282,354,000 | $0 | $-1,788,000 |
| Net Intangibles Purchase And Sale | $0 | $0 | $-7,535,000 | $-7,000,000 |
| Purchase Of Intangibles | $0 | $0 | $-7,535,000 | $-7,000,000 |
| Net PPE Purchase And Sale | $-142,481,000 | $-160,632,000 | $-175,921,000 | $-161,266,000 |
| Purchase Of PPE | $-142,481,000 | $-160,632,000 | $-175,921,000 | $-161,266,000 |
| Change In Working Capital | $-111,368,000 | $-240,259,000 | $-247,096,000 | $-114,093,000 |
| Change In Other Working Capital | $6,165,000 | $10,433,000 | $12,862,000 | $37,845,000 |
| Change In Other Current Liabilities | $-128,938,000 | $-105,476,000 | $-52,578,000 | $-52,075,000 |
| Change In Other Current Assets | $-4,883,000 | $-69,428,000 | $-28,588,000 | $-16,275,000 |
| Change In Payables And Accrued Expense | $61,585,000 | $-79,524,000 | $60,984,000 | $46,110,000 |
| Change In Payable | $61,585,000 | $-79,524,000 | $60,984,000 | $46,110,000 |
| Change In Account Payable | $61,585,000 | $-79,524,000 | $60,984,000 | $46,110,000 |
| Change In Inventory | $20,943,000 | $-45,443,000 | $-101,902,000 | $-67,250,000 |
| Change In Receivables | $-66,240,000 | $49,179,000 | $-137,874,000 | $-62,448,000 |
| Changes In Account Receivables | $-66,240,000 | $49,179,000 | $-137,874,000 | $-62,448,000 |
| Stock Based Compensation | $44,709,000 | $36,868,000 | $42,564,000 | $29,918,000 |
| Deferred Tax | $-877,000 | $-1,197,000 | $-31,988,000 | $16,633,000 |
| Deferred Income Tax | $-877,000 | $-1,197,000 | $-31,988,000 | $16,633,000 |
| Depreciation Amortization Depletion | $191,825,000 | $165,905,000 | $130,423,000 | $131,680,000 |
| Depreciation And Amortization | $191,825,000 | $165,905,000 | $130,423,000 | $131,680,000 |
| Amortization Cash Flow | $104,807,000 | $81,280,000 | $58,425,000 | $60,120,000 |
| Amortization Of Intangibles | $104,807,000 | $81,280,000 | $58,425,000 | $60,120,000 |
| Depreciation | $87,018,000 | $84,625,000 | $71,998,000 | $71,560,000 |
| Net Income From Continuing Operations | $637,834,000 | $642,234,000 | $707,755,000 | $692,843,000 |
| Unrealized Gain Loss On Investment Securities | - | $0 | $0 | $-9,707,000 |
| Gain Loss On Investment Securities | - | $-742,000 | - | - |
| Other Non Cash Items | - | - | $10,003,000 | - |
| Asset Impairment Charge | - | - | $0 | $0 |
| Taxes Refund Paid | - | - | - | $0 |